Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival

著者: David S. Alberts, Christian Marth, Ronald D. Alvarez, Gary A. Johnson, Mariusz Bidziński, David Kardatzke, Williamson Z. Bradford, Jeff Loutit, David H. Kirn, Mary C. Clouser, Maurie Markman - Gynecologic Oncology 2008 被引用: 129